Follow us on LinkedIn and get a free tote bag! Follow us

Bacteroides ovatus: PCR Detection and Clinical Overview


Bacteroides ovatus is a dominant anaerobic commensal bacterium in the human gut microbiota. Under normal conditions, it contributes to intestinal homeostasis and microbial balance. However, when the intestinal barrier is disrupted or microbiota imbalance occurs, it can transition into an opportunistic pathogen, leading to serious infections such as intra-abdominal abscesses, bacteremia, and post-surgical infections. Its strong antimicrobial resistance and toxin production further complicate clinical management.

Bacteroides ovatus is a dominant anaerobic commensal bacterium in the human gut microbiota. Under normal conditions, it contributes to intestinal homeostasis and microbial balance. However, when the intestinal barrier is disrupted or microbiota imbalance occurs, it can transition into an opportunistic pathogen, leading to serious infections such as intra-abdominal abscesses, bacteremia, and post-surgical infections. Its strong antimicrobial resistance and toxin production further complicate clinical management.

I Biological Characteristics

B. ovatus is a Gram-negative, non-spore-forming short rod with rounded ends.

It is an obligate anaerobe and highly sensitive to oxygen, requiring strictly anaerobic conditions for survival and growth.

The bacterium is bile-resistant, allowing stable colonization in the intestinal tract.

Key virulence factors include a polysaccharide capsule that inhibits phagocytosis and heparinase, which may promote thrombosis and facilitate bacterial dissemination.

II Antimicrobial Resistance Profile

B. ovatus exhibits significant resistance to multiple antibiotics.

Extended-spectrum β-lactamase (ESBL) production exceeds 40%, conferring resistance to many β-lactam antibiotics.

Resistance is also commonly observed against clindamycin and penicillin, and some strains demonstrate reduced susceptibility to fluoroquinolones such as moxifloxacin.

This resistance profile significantly limits therapeutic options and necessitates careful antibiotic selection.

III Culture Conditions and Colony Morphology

Culture is performed under strict anaerobic conditions at 37°C using media such as blood agar supplemented with vitamin K₁ and BBE agar.

Typical gas composition: 85% N₂, 10% H₂, and 5% CO₂, with incubation for approximately 48 hours.

On blood agar, colonies appear gray-white, circular, and convex (1–3 mm in diameter).

On BBE agar, colonies turn black due to esculin hydrolysis, a key identification feature.

Colonies often produce a characteristic foul odor due to short-chain fatty acid production.

IV Clinical Infections

Common infection sites include the abdominal cavity, pelvis, and bloodstream.

Intra-abdominal abscesses may occur following appendiceal rupture or gastrointestinal surgery.

Pelvic infections are often associated with gynecological procedures.

Bacteremia may develop when the intestinal mucosal barrier is compromised.

High-risk factors include colorectal cancer, intestinal surgery, and prolonged antibiotic use leading to microbiota imbalance.

V Laboratory Diagnosis

Specimens must be transported in anaerobic containers to preserve bacterial viability.

Direct microscopy reveals Gram-negative rods with polymorphic features.

Culture identification relies on anaerobic blood agar and BBE agar, with black colony formation on BBE as a key marker.

MALDI-TOF mass spectrometry enables rapid identification.

Antimicrobial susceptibility testing should follow CLSI standards using dedicated anaerobic panels.

VI Inactivation Methods

Effective sterilization methods include autoclaving at 121°C for 20 minutes or immersion in 2% glutaraldehyde for 45 minutes.

Environmental disinfection can be achieved using chlorine-based disinfectants (1000 mg/L) for 30 minutes or 0.5% peracetic acid spraying.

VII Clinical Treatment

First-line treatment includes metronidazole (intravenous) combined with β-lactamase inhibitors such as piperacillin/tazobactam.

Carbapenems (e.g., imipenem, meropenem) are also effective options.

Clindamycin should be avoided due to resistance rates exceeding 80%.

For ESBL-positive strains, cephalosporin monotherapy is not recommended.

In severe cases such as abscess formation, surgical or percutaneous drainage is essential, as antibiotics alone are insufficient.

PCR KIT

Related Product

Bacteroides ovatus Probe Realtime PCR Kit

Catalog No.: BF-66504405

This real-time PCR kit enables rapid, sensitive, and specific detection of Bacteroides ovatus, supporting clinical research, infection monitoring, and microbiome studies.

View Product →

Cautions:
For research use only.
Not intended for diagnostic or therapeutic use unless otherwise specified.

By teamBiofargo

Share:

Just added to your wishlist:
My Wishlist
You've just added this product to the cart:
Go to cart page